These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28469977)

  • 1. MiR-29a-3p suppresses cell proliferation in laryngocarcinoma by targeting prominin 1.
    Su J; Lu E; Lu L; Zhang C
    FEBS Open Bio; 2017 May; 7(5):645-651. PubMed ID: 28469977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Bone Marrow Mesenchymal Stem Cell (hBMSCs)-Derived miR-29a-3p-Containing Exosomes Impede Laryngocarcinoma Cell Malignant Phenotypes by Inhibiting PTEN.
    Yu T; Yu H; Xiao D; Cui X
    Stem Cells Int; 2022; 2022():8133632. PubMed ID: 36338027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA NEAT1 functions as an oncogene in human laryngocarcinoma by targeting miR-29a-3p.
    Liu T; Wang W; Xu YC; Li ZW; Zhou J
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6234-6241. PubMed ID: 31364125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced miR-9 promotes laryngocarcinoma cell survival via down-regulating PTEN.
    Lu E; Su J; Zeng W; Zhang C
    Biomed Pharmacother; 2016 Dec; 84():608-613. PubMed ID: 27694005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma.
    Wang X; Liu S; Cao L; Zhang T; Yue D; Wang L; Ping Y; He Q; Zhang C; Wang M; Chen X; Gao Q; Wang D; Zhang Z; Wang F; Yang L; Li J; Huang L; Zhang B; Zhang Y
    Oncotarget; 2017 Oct; 8(49):86592-86603. PubMed ID: 29156819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F6-Mediated Downregulation of MIR22HG Facilitates the Progression of Laryngocarcinoma by Targeting the miR-5000-3p/FBXW7 Axis.
    Chen H; Ali M; Ruben A; Stelmakh D; Pak M
    Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32094308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells.
    Chen Y; Zhang W; Yan L; Zheng P; Li J
    PeerJ; 2020; 8():e10148. PubMed ID: 33150075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of RPS15A by miR-29a-3p attenuates cell proliferation in colorectal carcinoma.
    Zheng Z; Cui H; Wang Y; Yao W
    Biosci Biotechnol Biochem; 2019 Nov; 83(11):2057-2064. PubMed ID: 31303129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29a-3p inhibits growth, proliferation, and invasion of papillary thyroid carcinoma by suppressing NF-κB signaling via direct targeting of OTUB2.
    Ma Y; Sun Y
    Cancer Manag Res; 2019; 11():13-23. PubMed ID: 30588107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-29a-3p negatively regulates circulating Tfh memory cells in patients with Graves' disease by targeting ICOS.
    Liu Y; Wang X; Luan W; Zou J; Xing J; Wang S; Peng H
    Immunol Res; 2023 Apr; 71(2):173-184. PubMed ID: 36322282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC.
    Xiao Z; Wang Y; Ding H
    Cell Biosci; 2019; 9():6. PubMed ID: 30627419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29a-5p Regulates the Proliferation, Invasion, and Migration of Gliomas by Targeting DHRS4.
    Dai Y; Chen Z; Zhao W; Cai G; Wang Z; Wang X; Hu H; Zhang Y
    Front Oncol; 2020; 10():1772. PubMed ID: 33014873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y Induces Cardiomyocyte Hypertrophy
    Xie Y; Hu J; Zhang X; Li C; Zuo Y; Xie S; Zhang Z; Zhu S
    Protein Pept Lett; 2020; 27(9):878-887. PubMed ID: 32297569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation and immunosuppressive function of CD19
    Li JY; Feng TS; Gao J; Yang XX; Li XC; Deng ZH; Xia YX; Wu ZS
    Hepatobiliary Pancreat Dis Int; 2024 Oct; 23(5):472-480. PubMed ID: 38724321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-29a up-regulation in AR42J cells contributes to apoptosis via targeting TNFRSF1A gene.
    Fu Q; Qin T; Chen L; Liu CJ; Zhang X; Wang YZ; Hu MX; Chu HY; Zhang HW
    World J Gastroenterol; 2016 May; 22(20):4881-90. PubMed ID: 27239114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma.
    Wang JY; Jiang JB; Li Y; Wang YL; Dai Y
    Biomed Pharmacother; 2017 Sep; 93():1047-1054. PubMed ID: 28738498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underexpression of CACNA1C Caused by Overexpression of microRNA-29a Underlies the Pathogenesis of Atrial Fibrillation.
    Zhao Y; Yuan Y; Qiu C
    Med Sci Monit; 2016 Jun; 22():2175-81. PubMed ID: 27341015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
    Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Zhou J; Huang CL; Liu HW; Zeng ZY; Tan J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1650-1654. PubMed ID: 36476884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells.
    Yu D; Tolleson WH; Knox B; Jin Y; Guo L; Guo Y; Kadlubar SA; Ning B
    Biochem Pharmacol; 2015 Dec; 98(4):671-80. PubMed ID: 26428001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.